Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II trial studies PT-100 combination therapy for advanced NSCLC

March 12, 2004

Novel poly(ADP-ribose) polymerase-1 inhibitor restores sensitivity to temozolomide

March 12, 2004

Pfizer researchers report new inhibitors of TRK and other kinases for cancer therapy

March 12, 2004

Schering-Plough and Pharmacopeia report new CXCR ligands and their use

March 12, 2004

Phenoxodiol evaluated in combination therapy for late-stage renal carcinoma

March 12, 2004

New phase I/IIa study to evaluate Telcyta combination therapy for NSCLC

March 11, 2004

Nippon Shinyaku scientists discover Bcr-Abl kinase inhibitors for use in leukemia therapy

March 11, 2004

Pfizer describes inhibitors of CDKs and tyrosine kinases and their therapeutic use

March 11, 2004

Progression of gene vector manufacturing for GeneMax TAP cancer vaccine

March 11, 2004

Bionomics anticancer IP advances into drug discovery

March 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...